378800 · KOSDAQ · ₩378800 · 샤페론
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−82.8% from the high
₩1,985Today: ₩2,285 – ₩2,385₩13,649
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
Shaperon (샤페론, KRX: 378800) is listed on KOSDAQ, in the Biotech & Pharma sector. Chaperone is a Korean biotech venture focused on new drug research and development. Its shares closed at ₩2,345 on Oct 27, 2026, up 0.64% on the day, giving it a market value of ₩22B.
Chaperone is a Korean biotech venture focused on new drug research and development. It holds a platform for inflammasome complex inhibitors that targets GPCR19, and a Nanomab antibody development platform. Its drug candidates include an atopic dermatitis treatment in clinical trials in the United States and an Alzheimer's treatment in clinical trials in Korea, and it also operates a small-molecule drug research center and an AI-based drug discovery platform.
Written by AI from the company's latest annual report.
Predicted impact: Low· Actual: −16.3% vs sector, volume 1.2× normal (5 trading days)
Co-development and technology transfer exploration is vague with no terms or value disclosed.
Predicted impact: Low· Actual: −16.3% vs sector, volume 1.2× normal (5 trading days)
Attendance at a bio event is routine; no deal, data, or financial size mentioned.
Titles in Korean until English translations are added.
Also known as: Shaperon / 샤페론 / 378800 / KRX:378800
Source: KRX statistical information